Conexeu Sciences Inc.
CNXU- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0002066836
No open-market purchases or sales by Conexeu Sciences Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $278.1K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +7 vs. previous quarter
- 7
- 13F valueReported value at the end of Q2 2026
- $278.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CNXU, Q2 2026
No superinvestor reported holding CNXU at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Conexeu Sciences Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 (view filing) | Jun 18 | 5 days | Purcell Lynn SebastianDirector, 10% Owner | PPurchase | +202.5K | $0.80 | +$162.0K | +8.0%2.73M after | |
| Jun 23, 2026 (view filing) | Jun 18 | 5 days | Purcell Lynn SebastianDirector, 10% Owner | PPurchase | +202.5K | $0.00 | $0 | –625.0K after | Derivative |
| May 14, 2026 (view filing) | May 12 | 2 days | Purcell Lynn SebastianDirector, 10% Owner | PPurchase | +422.5K | $0.80 | +$338.0K | +20.0%2.53M after | |
| May 14, 2026 (view filing) | May 12 | 2 days | Purcell Lynn SebastianDirector, 10% Owner | SSale | +422.5K | $0.00 | $0 | –625.0K after | DerivativeDuplicate filing |
| May 14, 2026 (view filing) | May 12 | 2 days | Purcell Lynn SebastianDirector, 10% Owner | PPurchase | +422.5K | $0.00 | $0 | –625.0K after | DerivativeDuplicate filing |
| May 14, 2026 (view filing) | May 12 | 2 days | OnePointTwo Capital Ventures LLC10% Owner | PPurchase | +422.5K | $0.80 | +$338.0K | +67.6%1.05M after | |
| May 14, 2026 (view filing) | May 12 | 2 days | OnePointTwo Capital Ventures LLC10% Owner | SSale | +422.5K | $0.00 | $0 | –625.0K after | Derivative |
| May 14, 2026 (view filing) | May 12 | 2 days | OnePointTwo Capital Ventures LLC10% Owner | PPurchase | +422.5K | $0.00 | $0 | –625.0K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Conexeu Sciences Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 12,264 | $133.9K | 0.00% | +12,264 | New |
| Morgan Stanley | 5,871 | $64.1K | 0.00% | +5,871 | New |
| Citigroup Inc | 5,219 | $57.0K | 0.00% | +5,219 | New |
| Hollencrest Capital Management | 1,000 | $10.9K | 0.00% | +1,000 | New |
| Royal Bank of Canada | 887 | $10.0K | 0.00% | +887 | New |
| Jones Financial Companies LLLP | 100 | $1.10K | 0.00% | +100 | New |
| Advisor Group Holdings, Inc. | 100 | $1.09K | 0.00% | +100 | New |